Therefore, antiangiogenic agents are often used in combination with chemotherapeutic drugs to achieve synergistic effects by normalizing tumor vessels to restore perfusion in order to enhance chemotherapeutic drug delivery.44 Despite BICC1 playing a crucial role in angiogenesis, there are currently no effective small-molecule inhibitors for BICC1. Here, BICC1 is linked to neoplasm.